Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Viropharma Inc.

Headquarters: Exton, PA, United States of America
Website: N/A
Year Founded: 1994
Status: Acquired

BioCentury | Aug 4, 2018
Finance

Functions of formulation

How Halozyme is growing its business around licensing reformulation technology
BioCentury | Jan 27, 2018
Finance

All together now

Why long-time independent small caps BioCryst, Idera decided to merge
BioCentury | Jan 12, 2018
Company News

Shire to split neuro and rare disease businesses

BioCentury | Jan 9, 2018
Company News

Shire splits neuro and rare disease businesses

BioCentury | Feb 9, 2017
Company News

Vancocin vancomycin news

BioCentury | Feb 8, 2017
Company News

FTC suit alleges Shire abused FDA process

BioCentury | Jan 18, 2016
Strategy

Shire's serial story

How Baxalta deal will help Shire evaluate new M&A opportunities
BioCentury | Jan 4, 2016
Product Development

Turnabout

Assessing the path forward for Chimerix's brincidofovir in adenovirus
BioCentury | Dec 19, 2015
Company News

Soland replaces Aldag as uniQure CEO

BioCentury | Nov 9, 2015
Finance

HAE maker

Why Shire thinks it's done buying assets in HAE
Items per page:
1 - 10 of 410